Americana Partners LLC Has $1.91 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Americana Partners LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,667 shares of the medical equipment provider’s stock after buying an additional 223 shares during the period. Americana Partners LLC’s holdings in Intuitive Surgical were worth $1,914,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Sierra Ocean LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $40,000. J.W. Cole Advisors Inc. grew its holdings in Intuitive Surgical by 10.7% during the fourth quarter. J.W. Cole Advisors Inc. now owns 3,708 shares of the medical equipment provider’s stock worth $1,935,000 after purchasing an additional 357 shares during the period. Csenge Advisory Group grew its holdings in Intuitive Surgical by 7.6% during the fourth quarter. Csenge Advisory Group now owns 2,260 shares of the medical equipment provider’s stock worth $1,180,000 after purchasing an additional 159 shares during the period. WD Rutherford LLC raised its stake in Intuitive Surgical by 9.9% in the fourth quarter. WD Rutherford LLC now owns 8,310 shares of the medical equipment provider’s stock valued at $4,337,000 after buying an additional 750 shares during the period. Finally, Allworth Financial LP lifted its position in shares of Intuitive Surgical by 35.8% in the fourth quarter. Allworth Financial LP now owns 11,364 shares of the medical equipment provider’s stock valued at $5,932,000 after buying an additional 2,998 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $595.55 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock’s fifty day moving average price is $559.48 and its two-hundred day moving average price is $520.19. The company has a market cap of $212.12 billion, a PE ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ISRG shares. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.